Compound Summary
allopurinol
Compound Information
allopurinol
Compound Name: | allopurinol |
Compound CID: | 135401907 |
Synonyms: | allopurinol 315-30-0 1H-Pyrazolo3,4-dpyrimidin-4-ol Zyloprim Zyloric More... |
Iupac Name: | 1,5-dihydropyrazolo[3,4-d]pyrimidin-4-one |
InChI: | InChI=1S/C5H4N4O/c10-5-3-1-8-9-4(3)6-2-7-5/h1-2H,(H2,6,7,8,9,10) |
InChIKey: | OFCNXPDARWKPPY-UHFFFAOYSA-N |
Canonical Smiles: | C1=NNC2=C1C(=O)NC=N2 |
Isomeric Smiles: | C1=NNC2=C1C(=O)NC=N2 |
Molecular Weight: | 136.11 |
Molecular Formula: | C5H4N4O |
Compound Structure
2D Structure:
3D Structure:
Computed Properties
allopurinol
Molecular Weight: | 136.11 |
Molecular Formula: | C5H4N4O |
Hydrogen Bond Donor Count: | 2 |
Hydrogen Bond Acceptor Count: | 3 |
Rotatable Bond Count: | 0 |
Heavy Atom Count: | 10 |
Complexity: | 190 |
Synonyms
allopurinol
| allopurinol | allopurinol |
|---|---|
allopurinol |
315-30-0 |
1H-Pyrazolo3,4-dpyrimidin-4-ol |
Zyloprim |
Zyloric |
Lopurin |
Atisuril |
Bleminol |
Caplenal |
Uripurinol |
Embarin |
Foligan |
Milurit |
Progout |
Urosin |
Anoprolin |
Cellidrin |
Epidropal |
Suspendol |
Ailural |
Allopur |
Allural |
Alositol |
Bloxanth |
Cosuric |
Hamarin |
Ledopur |
Lysuron |
Uricemil |
Uriprim |
Xanturat |
Aloral |
Anzief |
Apurin |
Apurol |
Geapur |
Gotax |
Remid |
Urbol |
Urolit |
Urtias |
Ketobun-A |
Apulonga |
Dabrosin |
Dabroson |
Ketanrift |
Miniplanor |
Nektrohan |
Takanarumin |
Urobenyl |
Adenock |
Allozym |
Aluline |
Gichtex |
Monarch |
Riball |
4-Hydroxypyrazolo3,4-dpyrimidine |
Hexanuret |
Epuric |
1H-Pyrazolo3,4-dpyrimidin-4(5H)-one |
Allo-Puren |
4-HPP |
Allopurinol(I) |
Dura Al |
Aloprim |
Urtias 100 |
4-Hydroxypyrazolopyrimidine |
1H-Pyrazolo(3,4-d)pyrimidin-4-ol |
4-Hydroxy-1H-pyrazolo(3,4-d)pyrimidine |
Allopurinolum |
Alopurinol |
4-Hydroxy-3,4-pyrazolopyrimidine |
4-Hydroxypyrazolo(3,4-d)pyrimidine |
Alopurinol INN-Spanish |
Allopurinolum INN-Latin |
NSC-1390 |
180749-08-0 |
1H-pyrazolo3,4-dpyrimidin-4(7H)-one |
4-Hydroxypyrazolyl(3,4-d)pyrimidine |
4H-Pyrazolo(3,4-d)pyrimidin-4-one |
4-Hydroxypyrazolol(3,4-d)pyrimidine |
180749-06-8 |
AL-100 |
BW 56-158 |
Zyloprim (TN) |
73334-58-4 |
1,5-Dihydro-4H-pyrazolo(3,4-d)pyrimidin-4-one |
2H-Pyrazolo3,4-dpyrimidin-4-ol |
4H-Pyrazolo3,4-dpyrimidin-4-one, 1,5-dihydro- |
B. W. 56-158 |
1,5-Dihydro-4H-pyrazolo(3,4-d)pyrimidine-4-one |
BW-56-158 |
UNII-63CZ7GJN5I |
180749-09-1 |
1,5-Dihydro-4H-pyrazolo3,4-dpyrimidin-4-one |
MLS000069453 |
4H-Pyrazolo(3,4-d)pyrimidin-4-one, 1,5-dihydro- |
CHEBI:40279 |
1H-pyrazolo3,4-dpyrimidin-4(2H)-one |
MFCD00599413 |
180749-07-9 |
184789-03-5 |
63CZ7GJN5I |
SMR000059083 |
4-Hydroxy-1H-pyrazolo3,4-dpyrimidine |
1H-Pyrazolo3,4-dpyrimidin-4-ol (9CI) |
4H-Pyrazolo3,4-dpyrimidin-4-one, 1,7-dihydro- (9CI) |
1,5-Dihydropyrazolo3,4-dpyrimidin-4-one |
1H,4H,5H-pyrazolo3,4-dpyrimidin-4-one |
NSC1390 |
4H-Pyrazolo3,4-dpyrimidin-4-one, 1,2-dihydro- |
NSC101655 |
NSC-101655 |
NCGC00015094-02 |
NCGC00094580-04 |
4H-Pyrazolo3,4-dpyrimidin-4-one, 2,5-dihydro- (9CI) |
4H-Pyrazolo3,4-dpyrimidin-4-one, 2,7-dihydro- (9CI) |
BW 56158 |
BW-56158 |
Sigapurol |
Uritas |
1H,2H,4H-pyrazolo3,4-dpyrimidin-4-one |
2H-Pyrazolo3,4-dpyrimidin-4-ol (9CI) |
DSSTox_CID_2573 |
1,5-Dihydro-pyrazolo3,4-dpyrimidin-4-one |
DSSTox_RID_76636 |
DSSTox_GSID_22573 |
pyrazolo5,4-dpyrimidin-4-ol |
4H-Pyrazolo3, 1,5-dihydro- |
Ailurial |
WLN: T56 BMN GN INJ FQ |
4-Hydroxypyrazolyl3,4-dpyrimidine |
4-Hydroxypyrazolol3,4-dpyrimidine |
NSC 1390 |
CAS-315-30-0 |
CCRIS 626 |
NSC 101655 |
HSDB 3004 |
SR-05000001983 |
EINECS 206-250-9 |
Hexanurat |
Uricto |
ATH008 |
Prestwick_511 |
Xanthomax-100 |
Xanthomax-300 |
4H-Pyrazolo3,4-dpyrimidin-4-one,1,2-dihydro- |
Aluline 100 |
Aluline 300 |
Hamarin 100 |
Hamarin 300 |
Zyloric-300 |
Allopurinol USAN:USP:INN:BAN:JAN |
Allopurinol (Zyloprim) |
Spectrum_000026 |
Opera_ID_1680 |
Spectrum2_000098 |
Spectrum3_000289 |
Spectrum4_000135 |
Spectrum5_000768 |
Lopac-A-8003 |
1,4-dpyrimidin-4-one |
A 8003 |
cid_2094 |
SCHEMBL4627 |
CHEMBL1467 |
NCIOpen2_001825 |
Lopac0_000102 |
BSPBio_001798 |
KBioGR_000550 |
KBioSS_000386 |
MLS001148183 |
US9138393, Allopurinol |
US9144538, Allopurinol |
DivK1c_000685 |
SPECTRUM1500108 |
SPBio_000056 |
GTPL6795 |
SCHEMBL1128219 |
Allopurinol (JP17/USP/INN) |
DTXSID4022573 |
BDBM35440 |
HMS502C07 |
KBio1_000685 |
KBio2_000386 |
KBio2_002954 |
KBio2_005522 |
KBio3_001298 |
NINDS_000685 |
BDBM181133 |
HMS1920A15 |
HMS2091G15 |
HMS2234M09 |
HMS3259K13 |
HMS3260E06 |
HMS3371I11 |
HMS3651O13 |
HMS3714L22 |
Pharmakon1600-01500108 |
4-Hydroxypyrazol3,4-Dpyrimidine |
ACT02732 |
AMY18272 |
BCP26973 |
HY-B0219 |
STR05189 |
Tox21_110082 |
Tox21_200922 |
Tox21_500102 |
2204AH |
4-Hydroxy-pyrazolo3,4-dpyrimidin |
AC-019 |
BBL002902 |
BBL009959 |
BDBM50016784 |
BDBM50140241 |
CCG-38916 |
NSC755858 |
s1630 |
SBB004202 |
SC1118 |
SC2251 |
STK378584 |
STK711106 |
ZINC13298313 |
AKOS000267490 |
AKOS000269759 |
AKOS024255717 |
Tox21_110082_1 |
Allopurinol, xanthine oxidase inhibitor |
CCG-204197 |
CCG-221406 |
CCG-266128 |
DB00437 |
LP00102 |
MCULE-5186178136 |
NC00492 |
NSC-755858 |
SB10164 |
SDCCGSBI-0050090.P005 |
IDI1_000685 |
NCGC00015094-01 |
NCGC00015094-03 |
NCGC00015094-04 |
NCGC00015094-05 |
NCGC00015094-06 |
NCGC00015094-07 |
NCGC00015094-08 |
NCGC00015094-22 |
NCGC00091134-01 |
NCGC00091134-02 |
NCGC00091134-03 |
NCGC00094580-01 |
NCGC00094580-02 |
NCGC00094580-05 |
NCGC00188948-01 |
NCGC00258476-01 |
NCGC00260787-01 |
291279-53-3 |
TS-00028 |
2h-pyrazolo3,4-dpyrimidin-4(5h)-one |
2H-pyrazolo3,4-dpyrimidin-4(7H)-one |
SBI-0050090.P004 |
AB0006119 |
AB0011633 |
AB0088254 |
DB-065332 |
A0907 |
EU-0100102 |
FT-0602537 |
FT-0661492 |
FT-0685730 |
FT-0764079 |
ST45179105 |
SW199406-4 |
1,5-dihydropyrazolo3,4-d-pyrimidin-4-one |
VU0611037-1 |
BIM-0061756.0001 |
D00224 |
F18007 |
32298-EP2272832A1 |
32298-EP2281815A1 |
32298-EP2292227A2 |
32298-EP2292630A1 |
32298-EP2295426A1 |
32298-EP2295427A1 |
32298-EP2301933A1 |
32298-EP2305219A1 |
32298-EP2305640A2 |
32298-EP2311825A1 |
32298-EP2311827A1 |
AB00173448-03 |
AB00173448-04 |
AB00173448_05 |
AB01274719-01 |
AB01274719_02 |
4h-pyrazolo3,4-dpyrimidin-4-one,1,7-dihydro- |
4h-pyrazolo3,4-dpyrimidin-4-one,2,5-dihydro- |
4h-pyrazolo3,4-dpyrimidin-4-one,2,7-dihydro- |
AB-323/25048497 |
Allopurinol (4-Hydroxypyrazolo3,4-dpyrimidine) |
Q412486 |
SR-01000075595 |
4H-pyrazolo3,4-dpyrimidin-4-one, 1,7-dihydro- |
J-504736 |
SR-01000075595-1 |
SR-05000001983-1 |
SR-05000001983-2 |
W-106892 |
1,7-DIHYDRO-PYRAZOLO3,4-DPYRIMIDIN-4-ONE |
1,2-DIHYDRO-4H-PYRAZOLO3,4-DPYRIMIDIN-4-ONE |
1,5-Dihydro-4H-pyrazolo(3,4-d)pyrimidin-4-one (9CI) |
F2173-0394 |
F3329-0375 |
Z228474686 |
Allopurinol, British Pharmacopoeia (BP) Reference Standard |
Allopurinol, European Pharmacopoeia (EP) Reference Standard |
Allopurinol, United States Pharmacopeia (USP) Reference Standard |
1,5-Dihydro-4H-pyrazolo3,4-dpyrimidin-4-one Synonym: Allopurinol |
Allopurinol, Pharmaceutical Secondary Standard; Certified Reference Material |
1H-Pyrazolo3,4-dpyrimidin-4-ol;1H-PYRAZOLO3,4-DPYRIMIDIN-4(5H)-ONE |
Experimental Data
allopurinol
| Species | Dose | Unit | Control(Avg days) | Treatment(Avg days) | Avg/Med Lifespan Change(%) | Control(Max days) | Treatment(Max days) | Max Lifespan Change(%) | Significant | Strain | Gender | PubMed | Avg/Med Lifespan Change tab |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Caenorhabditis elegans | 33.000000000000000 | umol/L | -10.000000000000000 | NS | N2 | 24134630 | Inactive |
Experimental Data Visualization
allopurinol
Statistics Data
allopurinol
| Species | Avg/Med Lifespan Change(%) | Max Lifespan Change(%) | Count Reference | Count Data point |
|---|---|---|---|---|
| Caenorhabditis elegans | -10.000000000000000 | 1 | 1 |
Statistics Data Visualization
allopurinol
